Method of treatment for multiple sclerosis
US4994466A · kind A · utility
22Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 1990 |
| Grant date | Feb 19, 1991 |
| Priority date | — |
| Expiry date | Jun 14, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.